MITCHELL BRODEY: Open Payments
NPI 1174501498 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,220 in 115 payments from 25 companies in 2025. Trend: 2023 $1,544 · 2024 $2,170 · 2025 $2,220
Food & beverage: $2,220
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $356 |
| ViiV Healthcare Company | 5 | $215 |
| Gilead Sciences, Inc. | 15 | $212 |
| Madrigal Pharmaceuticals | 8 | $210 |
| ABBVIE INC. | 15 | $206 |
| AstraZeneca Pharmaceuticals LP | 5 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $80 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
Products named: DOVATO, REZDIFFRA, Rybelsus, Ozempic, AIRSUPRA, CAPLYTA, Kerendia, JARDIANCE.
Industry payments across NY — which companies pay providers there.
